SEOM-GEICO clinical guidelines on endometrial cancer (2021)
Clin. transl. oncol. (Print)
; 24(4): 625-634, abril 2022. tab
Article
in En
| IBECS
| ID: ibc-203766
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
ABSTRACT
Endometrial cancer (EC) is the second most common gynecological malignancy worldwide, the first in developed countries [Sung et al. in CA Cancer J Clin 71209249, 2021]. Although a majority is diagnosed at an early stage with a low risk of relapse, an important proportion of patients will relapse. Better knowledge of molecular abnormalities is crucial to identify high-risk groups in early stages as well as for recurrent or metastatic disease for whom adjuvant treatment must be personalized. The objective of this guide is to summarize the current evidence for the diagnosis, treatment, and follow-up of EC, and to provide evidence-based recommendations for clinical practice.
Key words
Full text:
1
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Endometrial Neoplasms
Limits:
Female
/
Humans
Language:
En
Journal:
Clin. transl. oncol. (Print)
Year:
2022
Type:
Article